Icon

RHOPRESSA (nda208254)- (EQ 0.02% BASE)

NETARSUDIL MESYLATE ALCON LABS INC
EQ 0.02% BASE
Yes No
2034-Mar-14 2022-Dec-18
None None
None No
RHOPRESSA ® (netarsudil ophthalmic solution) 0.02% is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
1 1 0
Total Other Developers 14
Drugs with Suitability No
EQ 0.02% BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.